2.80% 0.045

Standard Biotools Inc (LAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Standard Biotools Inc-Aktie (LAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	61.56% 45.54	28.19	25.37	27.67	25.12
Cost Of Revenue	43.97% 21.35	14.83	14.21	14.06	12.78
Gross Profit	81.09% 24.19	13.36	11.15	13.60	12.34
Operating Expenses	142.84% 84.37	34.74	32.33	31.05	41.71
Benefits Costs and Expenses	61.18% 77.57	48.13	46.31	44.41	41.70
Costs And Expenses	61.18% 77.57	48.13	46.31	44.41	41.70
Operating Income/Loss	181.41% -60.18	-21.39	-21.17	-17.45	-16.59
Income/Loss From Continuing Operations Before Tax	60.64% -32.03	-19.94	-20.95	-16.74	-16.58
Income Tax Expense/Benefit	179.01% 0.128	-0.162	0.05	0.301	0.263
Income/Loss From Continuing Operations After Tax	62.61% -32.16	-19.78	-21.00	-17.04	-16.84
Net Income/Loss	62.61% -32.16	-19.78	-21.00	-17.04	-16.84
Preferred Stock Dividends And Other Adjustments	46.01	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	152.30K% 294.12	0.193	79.15	78.67	79.08
Diluted Average Shares	152.30K% 294.12	0.193	79.15	78.67	79.08
Basic Earnings Per Share	8.00% -0.27	-0.25	-0.27	-0.22	-0.21
Diluted Earnings Per Share	8.00% -0.27	-0.25	-0.27	-0.22	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	46.01	-	-	-	-

STE

$214.58

1.08%

ZBH

$108.72

0.42%

PHG

$26.34

0.13%

DXCM

$75.50

0.35%

GEHC

$84.31

0.33%

$70.86

1.78%